“Endoxifen Suppresses AKT Signaling and Induces Apoptosis in Breast Cancer Cells via Inhibition of Protein Kinase C Beta 1”

https://pubmed.ncbi.nlm.nih.gov/38114522

Endoxifen, a metabolite of the breast cancer drug tamoxifen, suppresses AKT signaling and induces apoptosis in breast cancer through inhibition of protein kinase C beta 1.